BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 22763818)

  • 21. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
    Mazzio EA; Soliman KF
    Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
    Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
    J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
    Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
    J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Valproic Acid on the Class I Histone Deacetylase 1, 2 and 3, Tumor Suppressor Genes p21WAF1/CIP1 and p53, and Intrinsic Mitochondrial Apoptotic Pathway, Pro- (Bax, Bak, and Bim) and anti- (Bcl-2, Bcl-xL, and Mcl-1) Apoptotic Genes Expression, Cell Viability, and Apoptosis Induction in Hepatocellular Carcinoma HepG2 Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2021 Feb; 22(S1):89-95. PubMed ID: 33576217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
    Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
    Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
    Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
    Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
    Wang ZT; Chen ZJ; Jiang GM; Wu YM; Liu T; Yi YM; Zeng J; Du J; Wang HS
    Cell Signal; 2016 May; 28(5):506-515. PubMed ID: 26876786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray.
    Lee HS; Park MH; Yang SJ; Jung HY; Byun SS; Lee DS; Yoo HS; Yeom YI; Seo SB
    Biol Pharm Bull; 2004 Oct; 27(10):1497-503. PubMed ID: 15467184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway.
    Dvory-Sobol H; Sagiv E; Liberman E; Kazanov D; Arber N
    Cancer; 2007 Jan; 109(2):188-97. PubMed ID: 17149756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of histone deacetylase in inhibiting invasion of human gastric carcinoma cell line SGC-7901 by PPARgamma-mediated pathway].
    Ma GD; Zhang CQ; Hou J; Zhang LY; Lin C
    Ai Zheng; 2009 Jul; 28(7):695-701. PubMed ID: 19624894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells.
    Majumdar G; Adris P; Bhargava N; Chen H; Raghow R
    BMC Genomics; 2012 Dec; 13():709. PubMed ID: 23249388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase 3 inhibits new tumor suppressor gene DTWD1 in gastric cancer.
    Ma Y; Yue Y; Pan M; Sun J; Chu J; Lin X; Xu W; Feng L; Chen Y; Chen D; Shin VY; Wang X; Jin H
    Am J Cancer Res; 2015; 5(2):663-73. PubMed ID: 25973305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.
    Murphy M; Ahn J; Walker KK; Hoffman WH; Evans RM; Levine AJ; George DL
    Genes Dev; 1999 Oct; 13(19):2490-501. PubMed ID: 10521394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
    Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
    Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231.
    Nakajima S; Niizeki H; Tada M; Nakagawa K; Kondo S; Okada F; Kobayashi M
    Oncol Rep; 2009 Jul; 22(1):143-8. PubMed ID: 19513516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancer.
    Yang Z; Jiang X; Zhang Z; Zhao Z; Xing W; Liu Y; Jiang X; Zhao H
    Cancer Gene Ther; 2021 Feb; 28(1-2):141-155. PubMed ID: 32655129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.